(Q51370454)

English

Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study.

scientific article published in November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21781152

Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study. (English)

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21781152

type 2 diabetes

0 references

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

author name string

D R Owens

1

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21781152

R Swallow

2

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21781152

K A Dugi

3

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21781152

H J Woerle

4

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21781152

publication date

1 November 2011

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21781152

Diabetic Medicine

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21781152

28

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21781152

11

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21781152

1352-1361

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21781152

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Robust improvements in fasting and prandial measures of beta-cell function with vildagliptin in drug-naïve patients: analysis of pooled vildagliptin monotherapy database

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared wi

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of BI 1356, an inhibitor of dipeptidyl peptidase 4, in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Binding to dipeptidyl peptidase-4 determines the disposition of linagliptin (BI 1356)--investigations in DPP-4 deficient and wildtype rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

The metabolism and disposition of the oral dipeptidyl peptidase-4 inhibitor, linagliptin, in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Pharmacokinetics of dipeptidylpeptidase-4 inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Efficacy and safety of initial combination therapy with linagliptin and pioglitazone in patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Incretin-based therapies: viewpoints on the way to consensus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Overview of the gliptin class (dipeptidyl peptidase-4 inhibitors) in clinical practice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Current antihyperglycemic treatment strategies for patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03387.X

21 January 2018

Identifiers

10.1111/J.1464-5491.2011.03387.X

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21781152

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21781152

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51370454&oldid=1234443554"